​Do cholesterol-reducing statins increase diabetes risk?

Statins are a class of medications widely prescribed to lower cholesterol levels and reduce the risk of cardiovascular events, such as heart attacks and strokes. While they have proven highly effective in managing cardiovascular health, there has been ongoing debate and research surrounding the potential link between statin use and an increased risk of developing diabetes.

Statins work by inhibiting the enzyme HMG-CoA reductase, a key player in the body's production of cholesterol. By lowering LDL (low-density lipoprotein) cholesterol levels, statins can reduce the risk of atherosclerosis, atherosclerotic cardiovascular disease, and related complications. Statins are commonly prescribed to individuals with a history of heart disease, high cholesterol, or those at an elevated risk of cardiovascular events.

​Taking cholesterol-reducing pills? Serious side effects you need to know​

The concern regarding diabetes risk stems from observations that some individuals using statins experience an increase in blood glucose levels. These observations have raised questions about whether statins might contribute to the development of diabetes or exacerbate existing diabetes. However, the relationship between statins and diabetes is far from straightforward. Research into the connection between statins and diabetes risk has yielded mixed results. Some studies have suggested a modest increase in the risk of developing diabetes among statin users, particularly in older adults or those with existing risk factors for diabetes. Other studies, however, have found no significant association between statin use and diabetes risk.

Several mechanisms have been proposed to explain the potential link between statins and diabetes risk:

Insulin Resistance: Statins may interfere with insulin sensitivity, making it more difficult for cells to respond to insulin and utilize glucose efficiently.

Beta-Cell Function: Statins could impair the function of pancreatic beta cells, responsible for insulin production, leading to inadequate insulin secretion.

Inflammation: Some studies suggest that statins might have anti-inflammatory effects, which can potentially mitigate diabetes risk, as inflammation plays a role in diabetes development.

Individual factors: Genetic predisposition and individual variations may influence how statins affect blood glucose levels, making the relationship complex and highly individualized.

"Statins, commonly prescribed for lowering cholesterol, have been associated with a slight increase in diabetes risk. While statins effectively reduce LDL cholesterol levels and lower the risk of cardiovascular events, some studies suggest that they may also elevate the risk of developing type 2 diabetes. This risk is more pronounced in individuals with preexisting risk factors for diabetes, like obesity or impaired glucose metabolism," says Dr. Arun C. Singh, Director- Endocrinology & Diabetology, Metro Hospital, Faridabad.

"The exact mechanism behind this connection remains unclear, but it's believed that statins may interfere with insulin production and sensitivity. It's important to note that the absolute risk increase is relatively small and must be weighed against the substantial cardiovascular benefits of statin therapy," Dr. Singh explains. "Healthcare providers consider an individual's overall health, cardiovascular risk, and diabetes risk factors when prescribing statins. For those with a high risk of heart disease, the benefits of statins typically outweigh the potential diabetes risk, but regular monitoring for blood sugar changes is advisable during statin treatment. Lifestyle modifications, such as diet and exercise, can also mitigate this risk," the expert adds.